Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial
- Posted on August 18, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial
Aug 18 (Reuters) - Amylyx Pharmaceuticals' experimental drug met its main goal in a late-stage trial for post-bariatric hypoglycemia, a condition marked by dangerously low blood sugar levels following weight-loss surgery, sending its shares up over 30% in premarket trading on Tuesday. In the 78-patient trial, the once-daily injection avexitide reduced low blood sugar episodes by 55% versus
